• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home ENT

Secondary mastoid obliteration improves quality of life for patients with chronic otitis media

byAndrew Bishara
September 27, 2013
in ENT, Surgery
Reading Time: 2 mins read
Secondary mastoid obliteration improves quality of life for patients with chronic otitis media
Share on FacebookShare on Twitter

Image: PD

1. When compared to primary mastoid obliteration, secondary obliteration resulted in a more pronounced, though not statistically significant, improvement in quality of life.

2. In both the secondary and primary obliteration groups, a significant improvement in quality of life was noted.

Evidence Rating Level: 2 (Good)

Study Rundown: During mastoidectomy, cavity obliteration and reconstruction of the bony external ear canal is often recommended. If the obliteration is not completed during the procedure (primary obliteration), the cavity may not heal and a secondary obliteration procedure may be necessary. The authors used the Glasgow Benefit Inventory to assess quality of life (QOL) changes in patients following primary and secondary mastoid cavity obliteration. A subsequent analysis demonstrated a more pronounced, though not statistically significant, QOL improvement in the secondary obliteration group. The much smaller number of patients in the secondary obliteration group may explain the lack of significance.

Click to read the study in Journal of Otolaryngology – Head & Neck Surgery

RELATED REPORTS

The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar

Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma

Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging

Relevant Reading: Quality-of-life assessment after primary and revision ear surgery using the chronic ear survey

In-Depth [retrospective cohort]: This study compared the QOL improvement in 46 patients who had primary mastoid cavity obliteration and 12 who needed secondary obliteration. The 58 patients completed the Glasgow Benefit Inventory, either in person or over the phone. In the secondary obliteration group 83% of the subjects reported improvement in QOL compared to only 72% in the primary obliteration group. The secondary group also reported greater improvement of QOL across the GBI subscales (general, physical, and social). While these differences were noted clinically, they were not statistically significant on a Mann Whitney U test (p = .10, p = .15, and p = .43 respectively).

By Amir Tarsha and Chaz Carrier

More from this author: Local excision inferior to major resection in T1-2 colon cancer and T2 rectal cancer

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Previous Post

Alefacept may be effective therapy in newly diagnosed type 1 diabetics

Next Post

Improved survival with bufulfan-cyclophosphamide combination vs total body irradiation

RelatedReports

Imaging and Intervention

The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar

September 18, 2026
Chronic Disease

Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma

September 18, 2026
Artificial Intelligence

Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging

September 18, 2026
Chronic Disease

Brepocitinib becomes first oral therapy approved for adult dermatomyositis

September 18, 2026
Next Post
Improved survival with bufulfan-cyclophosphamide combination vs total body irradiation

Improved survival with bufulfan-cyclophosphamide combination vs total body irradiation

The CRASH-2 trial: Tranexamic acid in trauma patients [Classics Series]

Pediatric post-operative intussusception more common in open surgery

Enriching fat grafts with stem cells improves outcomes

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.